Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies (Q33331110)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies |
scientific article |
Statements
1 reference
Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies (English)
1 reference
E K Rowinsky
1 reference
R Humphrey
1 reference
L A Hammond
1 reference
C Aylesworth
1 reference
L Smetzer
1 reference
M Hidalgo
1 reference
M Morrow
1 reference
L Smith
1 reference
A Garner
1 reference
J M Sorensen
1 reference
D D Von Hoff
1 reference
S G Eckhardt
1 reference
1 January 2000
1 reference
1 reference
18
1 reference
178-186
1 reference
Identifiers
1 reference
1 reference